153 related articles for article (PubMed ID: 30456352)
21. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
[TBL] [Abstract][Full Text] [Related]
22. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
Subba Rao G; Vijayakrishnan R; Kumar M
Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
[TBL] [Abstract][Full Text] [Related]
23. High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis.
Sullivan TJ; Truglio JJ; Boyne ME; Novichenok P; Zhang X; Stratton CF; Li HJ; Kaur T; Amin A; Johnson F; Slayden RA; Kisker C; Tonge PJ
ACS Chem Biol; 2006 Feb; 1(1):43-53. PubMed ID: 17163639
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
[TBL] [Abstract][Full Text] [Related]
25. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
Yıldırım E; Uzun M
Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
[TBL] [Abstract][Full Text] [Related]
26. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of novel
Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
[TBL] [Abstract][Full Text] [Related]
28. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
Unissa AN; Subbian S; Hanna LE; Selvakumar N
Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
[TBL] [Abstract][Full Text] [Related]
29. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
[TBL] [Abstract][Full Text] [Related]
30. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
[TBL] [Abstract][Full Text] [Related]
31. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598
[TBL] [Abstract][Full Text] [Related]
32. Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
Bollela VR; Namburete EI; Feliciano CS; Macheque D; Harrison LH; Caminero JA
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1099-104. PubMed ID: 27393546
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance.
Dobner P; Rüsch-Gerdes S; Bretzel G; Feldmann K; Rifai M; Löscher T; Rinder H
Int J Tuberc Lung Dis; 1997 Aug; 1(4):365-9. PubMed ID: 9432394
[TBL] [Abstract][Full Text] [Related]
34. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
Kiepiela P; Bishop KS; Smith AN; Roux L; York DF
Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383
[TBL] [Abstract][Full Text] [Related]
35. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
[TBL] [Abstract][Full Text] [Related]
36. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
37. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.
Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W
J Clin Microbiol; 2006 Oct; 44(10):3659-64. PubMed ID: 17021094
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of genotype MTBDRplus assay for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis clinical isolates from Pakistan.
Javed H; Jamil N; Jagielski T; Bakuła Z; Tahir Z
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S147-S148. PubMed ID: 28043516
[TBL] [Abstract][Full Text] [Related]
39. An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors.
Chollet A; Maveyraud L; Lherbet C; Bernardes-Génisson V
Eur J Med Chem; 2018 Feb; 146():318-343. PubMed ID: 29407960
[TBL] [Abstract][Full Text] [Related]
40. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.
Zhang M; Yue J; Yang YP; Zhang HM; Lei JQ; Jin RL; Zhang XL; Wang HH
J Clin Microbiol; 2005 Nov; 43(11):5477-82. PubMed ID: 16272473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
